tiprankstipranks
Trending News
More News >
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market

Huakang Biomedical Holdings Company Limited (8622) Revenue

Compare
0 Followers

Huakang Biomedical Holdings Company Limited Revenue

Huakang Biomedical Holdings Company Limited had a revenue of 6.72M in the quarter ending Dec 31, 2024, with 0.00%. This bring the company's revenue in the last twelve months to 25.36M, Increased -0.53%. In the fiscal year ending Dec 31, 2024, Huakang Biomedical Holdings Company Limited had annual revenue of 25.36M with 2.96% growth.
Revenue (ttm)
25.36M
Revenue Growth
1.13%
P/S Ratio
7.30
Revenue/Employee
HK$278,670
Employees
91
Market Cap
HK$185.17M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
25.36M730.00K+2.96%
Dec 31, 2023
24.63M-701.00K-2.77%
Dec 31, 2022
25.33M-797.00K-3.05%
Dec 31, 2021
26.13M4.16M+18.94%
Dec 31, 2020
21.97M-3.50M-13.76%
Dec 31, 2019
25.47M-3.21M-11.18%
Dec 31, 2018
28.68M2.14M+8.05%
Dec 31, 2017
26.54M1.13M+4.45%
Dec 31, 2016
25.41M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis